| Company name | Ticker | Asset type | Sector | Market cap | % in ETF |
|---|---|---|---|---|---|
| LLY | Stock | Healthcare | US$ 1.02 T | 10,93% | |
| JNJ | Stock | Healthcare | US$ 663.28 B | 7,53% | |
| ABBV | Stock | Healthcare | US$ 459.82 B | 5,33% | |
| MRK | Stock | Healthcare | US$ 370.89 B | 4,29% | |
| UNH | Stock | Healthcare | US$ 358.73 B | 4,16% | |
| ROP | Stock | Healthcare | US$ 283.89 B | 3,60% | |
| NOVN | Stock | Healthcare | US$ 221.13 B | 3,29% | |
| AZN | Stock | Healthcare | US$ 243.34 B | 2,90% | |
| AMGN | Stock | Healthcare | US$ 240.11 B | 2,72% | |
| TMO | Stock | Healthcare | US$ 228.66 B | 2,70% | |
| ABT | Stock | Healthcare | US$ 188.69 B | 2,26% | |
| GILD | Stock | Healthcare | US$ 187.51 B | 2,14% | |
| PFE | Stock | Healthcare | US$ 164.21 B | 1,90% | |
| VRTX | Stock | Healthcare | US$ 141.42 B | 1,63% | |
| BMY | Stock | Healthcare | US$ 136.49 B | 1,60% | |
| DHR | Stock | Healthcare | US$ 148.35 B | 1,60% | |
| ISRG | Stock | Healthcare | US$ 131.38 B | 1,58% | |
| CVS | Stock | Healthcare | US$ 124.32 B | 1,40% | |
| MDT | Stock | Healthcare | US$ 120.46 B | 1,37% | |
| SYK | Stock | Healthcare | US$ 118.14 B | 1,31% | |
| MCK | Stock | Healthcare | US$ 107.42 B | 1,27% | |
| GSK | Stock | Healthcare | US$ 94.23 B | 1,20% | |
| SAN | Stock | Healthcare | US$ 193.67 B | 1,15% | |
| ELV | Stock | Healthcare | US$ 89.95 B | 1,02% | |
| REGN | Stock | Healthcare | US$ 86.84 B | 0,98% | |
| CI | Stock | Healthcare | US$ 75.64 B | 0,85% | |
| BSX | Stock | Healthcare | US$ 68.04 B | 0,84% | |
| HCA | Stock | Healthcare | US$ 89.85 B | 0,77% | |
| ARGX | Stock | Healthcare | US$ 57.16 B | 0,74% | |
| CSL | Stock | Healthcare | US$ 13.08 B | 0,71% | |
| COR | Stock | Healthcare | US$ 63.15 B | 0,71% | |
|
Takeda Pharmaceutical Co. Ltd.
|
4502 | - | Healthcare | - | 0,67% |
| EL | Stock | Healthcare | US$ 37.58 B | 0,66% | |
Bayer AG NA
|
BAYN | Stock | Healthcare | US$ 44.15 B | 0,66% |
| CAH | Stock | Healthcare | US$ 57.49 B | 0,65% | |
| BDX | Stock | Healthcare | US$ 50.32 B | 0,63% | |
|
Hoya Cor
|
7741 | - | Healthcare | - | 0,62% |
| EW | Stock | Healthcare | US$ 51.76 B | 0,61% | |
Lonza Group AG
|
LONN | Stock | Healthcare | US$ 39.50 B | 0,59% |
| HUM | Stock | Healthcare | US$ 48.22 B | 0,54% | |
Haleon PLC
|
HLN | Stock | Healthcare | US$ 38.70 B | 0,53% |
| IQV | Stock | Healthcare | US$ 43.80 B | 0,52% | |
| IDXX | Stock | Healthcare | US$ 41.70 B | 0,52% | |
| NTRA | Stock | Healthcare | US$ 59.15 B | 0,52% | |
| A | Stock | Healthcare | US$ 42.54 B | 0,51% | |
| TEVA | Stock | Healthcare | US$ 46.10 B | 0,50% | |
| VEEV | Stock | Healthcare | US$ 44.54 B | 0,49% | |
| WAT | Stock | Healthcare | US$ 40.20 B | 0,48% | |
|
Galderma Group N
|
GALD | Stock | Healthcare | US$ 37.44 B | 0,45% |
| ALC | Stock | Healthcare | US$ 27.70 B | 0,42% |
Average Investor10 user rating
4.0
(0 people)
SPDR® MSCI World Health Care UCITS ETF GBP (Ireland) is an exchange-traded fund (ETF), with assets under management totaling $568.49 million.
Over the past 12 months, SPDR® MSCI World Health Care UCITS ETF GBP recorded a return of 11.75%, with its price trading between $62.63 and $86.99 during the same period.
The ETF is traded under the ticker HEAW.
The current price of HEAW is $71.40. You can track the real-time price chart, review historical performance, and access detailed information about this ETF on the platform.
HEAW is currently trading at $71.40, with a market capitalization of approximately $568.490.000,00. Over the past year, the ETF has delivered a 11.75% return, based on share price performance.
Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.
You can invest in HEAW through a brokerage account that provides access to the exchange where it is listed. After opening and funding your account, search for the ticker symbol HEAW, select the number of shares you wish to purchase, and place your order.
In certain markets, similar exposure may also be available through locally listed products that track the same index.
Over the past month, HEAW has returned 0.68%, and 11.75% over the past year.
If you were to purchase 100 shares of HEAW at the current price of $71.40, your total investment would be $7,140.00.
After 1 month the profitability would be $7,188.55.
Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.
Sign in with your social account or email
Create your account
Already have an account? Login
Tesla
Dividend Schedule
Ranking of Stocks
Ranking of Brazilian ETFs
Crypto Rankings
